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Abstract
Both mammography and standard ultrasound (US) rely upon subjective criteria within 
the breast imaging reporting and data system (BI-RADS) to provide more uniform inter-
pretation outcomes, as well as differentiation and risk stratification of associated abnor-
malities. In addition, the technical performance and professional interpretation of both 
tests suffer from machine and operator dependence. We have been developing a new 
technique for breast imaging that is based on ultrasound tomography which quantifies 
tissue characteristics while also producing 3-D images of breast anatomy. Results are pre-
sented from clinical studies that utilize this method. In the first phase of the study, ultra-
sound tomography (UST) images were compared to multi-modal imaging to determine 
the appearance of lesions and breast parenchyma. In the second phase, correlative com-
parisons with MR breast imaging were used to establish basic operational capabilities of 
the UST system. The third phase of the study focused on lesion characterization. Region 
of interest (ROI) analysis was used to characterize masses. Our study demonstrated a 
high degree of correlation of breast tissue structures relative to fat subtracted contrast-
enhanced MRI and the ability to scan ~90% of the volume of the breast at a resolution of 
0.7 mm in the coronal plane.
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1. Introduction
Breast cancer is the most common cancer among women, accounting for one-third of cancers 
diagnosed. Statistically, ~230,000 new cases of invasive breast cancer and ~63,000 in situ breast 
carcinomas are diagnosed in the US annually; breast cancer is the third leading cause of cancer 
death among women, causing ~40,000 deaths in the US every year [1]. According to SEER sta-
tistics, approximately 61% of women are found to have localized breast cancers at the time of 
diagnosis; about 31% are found to be regional disease; another 5% are diagnosed with distant 
metastases while about 3% are unstaged [2]. The 5-year survival rate for women with localized 
© 2018 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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cancer is 98%; for those with regional disease, it drops to 84%; for those diagnosed with distant 
stage, the survival rate drops dramatically to 23%; while for unstaged cancers the 5-year sur-
vival rate is about 58%. Figure 1 illustrates the dependence of survival on cancer stage.
There are many reasons why cancers are not detected early but some of the major fac-
tors relate to limited participation in breast screening and the performance of screening 
mammography.
1.1. Limited participation in screening
National cancer screening statistics indicate that only 51% of eligible women undergo annual 
mammograms [4]. That rate is even lower for African American women and/or those of 
lower socioeconomic groups. Access, fear of radiation and discomfort are some of the factors 
that contribute to the low participation rate. Greater participation would lead to detection 
of breast cancer at an earlier stage leading to longer survival. Increased participation and 
improved breast cancer detection would have the greatest effect on the statistic of nearly 1 in 3 
women who are diagnosed each year with later stage (regional or greater) breast cancer, total-
ing approximately 60,000 women per year in the USA. The net effect would be an increase 
in survival time and a corresponding decrease in mortality rates. This is also suggested in a 
recent meta-analysis, whereby increased participation and sensitivity lead to additional inva-
sive cancer detection and greater mortality reduction [4].
1.2. Limited performance of mammography
For women with dense breast tissue, who are at the highest risk for developing breast cancer 
[5–8], the performance of mammography is at its worst [9]. Consequently, many cancers are 
Figure 1. The dependence of mortality rates on cancer type and stage. From Kerlikowske et al. [3].
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missed at their earliest stages when they are the most treatable. Improved cancer detection 
for women with denser breasts would decrease the proportion of breast cancers diagnosed at 
later stages, which would significantly lower the mortality rate.
1.3. The breast screening challenge
X-ray mammography detects about 5 cancers per 1000 screens [10]. However, its positive 
predictive value (PPV) is low and its sensitivity is greatly reduced in women with dense 
breast tissue [10]. Although digital breast tomosynthesis (DBT) may improve upon some 
of the limitations of standard mammography, it is unlikely to create a paradigm shift in 
performance [11] while generating even higher levels of ionizing radiation [12]. MRI can 
significantly improve on these limitations by virtue of its volumetric, radiation-free imag-
ing capability. Studies have shown that MRI can have a positive impact in the breast man-
agement continuum ranging from risk assessment to diagnosis and treatment monitoring 
[12, 13]. However, MRI can have a high false positive rate, requires contrast injection and 
the exams can be both long and costly [14]. Furthermore, MR has long been prohibitively 
expensive for routine use and there is a need for a low-cost equivalent alternative. Yet, 
for high-risk women, MRI is now viewed as the gold standard for breast cancer detection 
and screening [15–23]. Positron emission tomography is also limited by cost and radiation 
concerns.
Recent studies have demonstrated the effectiveness of hand held ultrasound imaging in 
detecting breast cancer, particularly for women with dense breasts (Table 1). These studies 
have shown that up to 4.5 extra cancers were detected per 1000 screens [24–34]. A strik-
ing aspect of the added detections is that they are predominantly node negative invasive 
cancers which would have potentially progressed to a later stage before possible mam-
mographic detection. Moreover, there is little risk of over detection of ductal carcinoma 
in situ (DCIS). The sensitivity of mammography is greater for DCIS than it is for invasive 
cancer, with DCIS making up approximately 25% of mammographic screen-detected breast 
cancers [35].
We have examined the data from these studies to extract the statistics of cancer detection 
by imaging mode (Table 1). The results are summarized in Figure 2. It is striking to note 
that ultrasound (US) almost doubles the cancer detection rate in dense breasts. However, 
despite these successful study outcomes, handheld ultrasound is unlikely to be adopted 
for screening because it is operator dependent, and its imaging aperture is small, which 
hinders whole breast imaging. Furthermore, ultrasound’s increased sensitivity to invasive 
cancer is offset by lowered sensitivity to DCIS by virtue of mammography’s greater abil-
ity to detect microcalcifications. Although such a trade-off may be justified by the fact that 
mortality from invasive cancers is much higher than that from DCIS, a combined screening 
[mammography plus automated breast ultrasound (ABUS)] would provide a comprehen-
sive screen. It has therefore been proposed that ABUS be used for screening, supplemental 
to mammography.
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To that end, automated breast ultrasound (ABUS) has been introduced as a way of overcom-
ing these issues, mainly by reducing operator dependence and increasing the field of view. 
For example, the GE Invenia ABUS ultrasound system for breast cancer screening, originally 
developed by U-Systems., recently received screening approval, adjunctive to mammogra-
phy, from the FDA, because it demonstrated an ability to detect cancers missed by mam-
mography in dense breasts. The SomoInsight screening study [24], indeed showed that ABUS 
plus mammography outperformed mammography alone, leading to the first FDA approval 
for ultrasound screening for breast cancer.
The fundamental quandary of breast screening today is the knowledge that (i) mammography misses 
cancers in dense breasts, (ii) that Automated Breast ultrasound (ABUS) detects cancers that mam-
mography misses and yet (iii) screening continues largely with mammography only. This paradox 
Figure 2. Venn diagram summarizing comparative cancer detection rates for screening mammography and ultrasound.
Author (Year) Center Type Exams US only cancers Yield per 1000
Brem et al. (2014) Multi ABUS 15,318 30 1.96
Berg et al. (2012) Multi HHUS 7473 32 4.28
Hooley et al. (2012) Single HHUS 935 3 3.21
Kelly et al. (2010) Multi AWBU 6425 23 3.58
Corsetti et al. (2008) Multi HHUS 9157 37 4.04
Crystal et al. (2003) Single HHUS 1517 7 4.61
Leconte et al. (2003) Single HHUS 4236 16 3.78
Kolb et al. (2002) Single HHUS 13,547 37 2.73
Kaplan (2001) Single HHUS 1862 6 3.22
Buchberger et al. (2000) Single HHUS 8103 32 3.95
Gordon et al. (1995) Single HHUS 12,706 44 3.46
Table 1. Summary of studies used in the analysis.
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is amplified even further by the proliferation of state breast density notification laws in the 
USA which mandate that this information be available to women undergoing breast cancer 
screening. The primary reason this paradox exists today is that ABUS screening increases 
call back rates (up to a factor of two in case of the SomoInsight study [23]). The improvement 
in classification performance, measured by the area under the ROC curve, is modest because 
the increase in sensitivity is partially offset by an increase in false positives thus slowing 
its adoption. Technically, with its basic B-mode capability, ABUS has the same issue with 
false positives as hand held ultrasound. It is therefore unlikely that ABUS will be widely 
adopted for screening in the foreseeable future without more tissue-specific imaging capa-
bility. Improved lesion characterization would help lower the barriers to adoption of screen-
ing ultrasound.
1.4. Potential role of UST
Ultrasound tomography (UST) is an emerging technique that has the potential for tissue-spe-
cific imaging and characterization, by virtue of its transmission imaging capability [36–61]. 
Improved specificity would lower call back rates and lower the barriers to adoption. An adjunc-
tive use of UST would have the potential to improve specificity relative to current ABUS and 
provide a comprehensive screen that would uncover invasive cancers otherwise missed by 
mammography. Detection of such early stage invasive cancers would provide women with 
curative treatment, the opportunity for which might be otherwise lost.
Conventional reflection ultrasound exploits differences in acoustic impedance between tis-
sue types to provide anatomical images of breast tumors [62, 63]. However, reflection is just 
one aspect of a multi-faceted set of acoustic signatures associated with the biomechanical 
properties of tissue. UST is a technique that moves beyond B-mode imaging by virtue of its 
transmission capabilities. The latter provides additional characterization by measuring tissue 
parameters such as sound speed and attenuation (ATT) [64–68]. These parameters can be used 
to characterize lesions in a quantitative manner, a capability not available in current whole 
breast ultrasound systems. By merging reflection images with images of the bio-acoustic 
parameters of sound speed and attenuation, UST offers the possibility of exploiting differ-
ences in anatomical and physical properties of tissue to accurately differentiate cancer from 
normal tissue or benign disease. UST parameters are also quantitative, which allows new con-
sideration of second and third-order statistical image analyses, or radiomics. Ultrasound has 
previously not been suitable for the burgeoning applications of radiomics due to its lack of 
true quantitative parameters such as sound speed (m/s) and attenuation (dB/cm/MHz). Initial 
assessments of UST performance was carried out, as described below.
In an initial attempt to assess the potential of UST in breast imaging, studies were carried 
out at the Karmanos Cancer Institute, Detroit, MI, USA. Informed consent was obtained 
from all patients, prospectively recruited in an IRB-approved protocol following HIPAA 
guidelines. Patients were scanned at the Alexander J Walt Comprehensive Breast Center. 
Standard multi-modality imaging was available for all patients. The Walt Breast Center 
houses SoftVue, a UST system manufactured by Delphinus Medical Technologies, Inc 
(Novi, MI). SoftVue embodies a number of attributes that differentiate it from conventional 
imaging modalities:
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• Water-based pulse coupling: SoftVue utilizes a water filled imaging chamber that is kept at 
body temperature. Its primary purpose is to couple the sound energy between the trans-
ducer and the breast tissue.
• Closed geometry probe: A circular ring transducer surrounds the breast while both are im-
mersed in water. There is no compression of the breast since the transducer is offset from 
the breast with water acting as the pulse coupling agent. The closed transducer geometry 
allows collection of signals that pass through the entire width of the breast, a requirement 
for transmission imaging and the reconstruction of sound speed and attenuation images. 
These parameters provide quantitative information in absolute units that are tied to exter-
nals standards (km/s and dB/cm, respectively).
• Operator independence: Unlike mammography and other ABUS systems, multiple position-
ings are not required for larger breasts. Once the patient is positioned on the table, the op-
erator simply presses the button and the exam is performed automatically without further 
intervention from the operator.
• Scan time: SoftVue scan time is 1–2 min per breast (depending on breast size). This scan 
duration minimizes intra-slice and inter-slice motion artifacts.
• Image reconstruction time. In this study, reconstruction time for a bilateral breast exam was 
~30 min for the average patient and current hardware/software processing ability.
SoftVue was used to scan the recruited patients for this study. Coronal image series were 
produced by tomographic algorithms for reflection, sound speed and attenuation. All images 
were reviewed by a board-certified radiologist who has more than 20 years of experience 
in breast imaging and US-technology development. Symptomatic study participants were 
scanned with a SoftVue UST system. Pathological correlation was based on biopsy results and 
standard imaging (e.g. US definitive cyst).
Tomographic algorithms were used to generate images stacks of reflectivity, sound speed and 
attenuation for each patient. Lesions were identified based on correlation with standard imag-
ing so that the tumor sound speed (SS) and attenuation (ATT) could be assessed. An example 
each type of image is shown in Figure 3.
In the first phase of the study, correlative comparisons with multi-modal imaging were car-
ried out to assess lesion properties relative to mammography, US and MR. In the second 
Figure 3. From left to right, reflection, sound speed and attenuation image slices depicting breast parenchyma and a 
fibroadenoma at 7 o’clock.
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phase, MR breast imaging was used to establish basic operational capabilities of the UST sys-
tem including the identification and characterization of parenchymal patterns, determination 
of the spatial resolution of UST and an estimate the breast volume that can imaged with UST. 
The third phase of the study focused on lesion characterization. Region of interest (ROI) anal-
yses were performed on all identified lesions using all three UST image types. Combinations 
of the ROI generated quantitative values were used to characterize all masses, particularly in 
relation to relative differences with surrounding peritumoral regions.
2. Multi-modal comparisons
Since the patients were recruited at KCI on the basis of having a suspicious finding, stan-
dard imaging such as mammography, US and sometimes MRI were available, as well as 
the radiology and pathology reports. These images and the associated reports were used to 
retroactively locate the lesions in the UST image stacks for visual comparison. Figures 4–7 
show examples of UST images in relation to the other modalities. When MRI was available, 
the images were projected into the coronal plane for easier comparison with the UST whose 
native format is coronal.
Figure 4 shows a 9mm IDC at 3 o’clock. CC and MLO mammographic views of the affected 
breast are shown on the left with the lesion identified by arrows. The UST views corresponding 
Figure 4. A 9 mm IDC at 3 o’clock. CC and MLO mammographic views of the affected breast are shown on the left with 
the lesion identified by arrows. The coronal UST views are shown in the form of reflection, sound speed and attenuation 
images. The corresponding ultrasound and MR images are also shown.
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Figure 5. Multimodality images compared to UST reflection, sound speed and attenuation. An IDC is shown at 12 
o’clock.
Figure 6. Multimodality images vs UST reflection, sound speed and attenuation showing an IDC and intramammary 
lymph node.
Breast Imaging
to the coronal planes that contain the lesions are across the top with reflection, sound speed and 
attenuation images laid out from left to right. The corresponding ultrasound and MR images 
are shown along the bottom. Inspection of the images shows good correspondence in shape 
and location of the lesion. The greatest similarity is between the UST images and MRI. The IDC 
is seen to be hypoechoic in reflection and has high sound speed and attenuation contrast. An 
IDC in a heterogeneously dense breast is shown in Figure 5 This IDC was initially missed by 
mammography. A large IDC and an intramammary lymph node are shown in Figure 6. Note 
the concordance between the UST images and mammography. Figure 7 illustrates the chest 
wall access achievable by UST relative to mammography. Although UST does not access the 
entire axilla it does visualize the cancer that has invaded the chest wall.
3. MR concordance
UST and MR imaging was performed within weeks of each other. UST imaging was carried out 
with the SoftVue system (Delphinus Medical Technologies) and the MR exams with a Philips 
Achieva 3T system. The resulting image sequences were qualitatively and quantitatively to 
assess imaging performance of UST. As discussed above, UST images correlate best with MR 
images. Further inspection shows that of the three UST image types, the sound speed image 
correlates best with MR. Figure 8 shows a coronal view comparison between UST speed of 
sound and MR contrast-enhanced fat subtracted images of representative breast parenchyma.
Figure 7. Illustrating the chest wall access achievable by UST relative to mammography.
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The parenchymal patterns are very similar with the only major difference relating to the shape 
of the breast. This difference can be explained by the fact that the SoftVue system utilizes 
water so that buoyancy foreshortens the breast while with MR, gravity lengthens the breast in 
the AP dimension (i.e. prone).
As discussed above, UST images correlate best with MR images. Further inspection shows that 
of the three UST image types, the sound speed image correlates best with MR, as illustrated in 
Figure 8. The parenchymal patterns are very similar with the only major difference relating to the 
shape of the breast. This difference can be explained by the fact that the SoftVue system utilizes 
water so that the buoyancy force helps shape the breast while with MR, gravity shapes the breast.
4. Breast volume comparisons
MRI was used as the gold standard for defining the extent of the breast tissue. MRI and UST 
breast volumes were compared using a paired t-test. In the first step, a k-means segmentation 
algorithm was applied to T1 breast MR images to automatically separate out the non-tissue 
background. In the second step, the boundary between the breast tissue and the chest wall 
was drawn manually and the chest wall removed, leaving behind only breast tissue (Figure 9).
In the UST images a semi-automated tool was used to draw a boundary around the breast 
tissue in each coronal slice and everything outside the boundary removed (water signal). Any 
slices containing chest wall signal were also removed. The resulting stack of slices then repre-
sented the pure breast volume scanned by UST.
The two sets of volumes were plotted against each other as shown in Figure 10. The average breast 
volumes for MRI and UST were compared and the result shown in Table 2. As expected, the UST 
Figure 8. Top: Coronal UST sound speed images for six different patients. Bottom: Corresponding fat subtracted 
contrast-enhanced MR images.
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Figure 9. The segmentation process for MR images (top) and UST images (bottom). From left to right, original image, 
segmentation boundary and the final segmented image.
Figure 10. Correlation between UST and MR measured breast volumes.
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scanned volume was less than that of MRI and was found to be about 89% of the MRI volume on 
average. However, a student’s paired t-test indicates that this difference is not significant. Since 
UST cannot fully access the axilla, it is likely that the UST scanned volume is somewhat lower 
than that of MRI, even though UST generally reaches the pectoralis muscle at the chest wall.
5. Spatial resolution assessment
The spatial resolution of each modality was estimated using profile cuts of thin features using, 
the full-width, half-maximum criterion as shown in Figure 11. The results of the spatial reso-
lution analysis are shown in Table 3. The spatial resolution was found to be dependent on 
the reprojection type for both MRI and with UST outperforming MRI in the coronal plane 
and MRI outperforming UST in the other projections. (However, MR acquisitions with isotro-
pic voxels would show comparable resolution to UST in the coronal plane). The UST image 
voxels are not isotropic and data acquisition cannot be readily adjusted like MR, such that 
UST reconstructed in axial and sagittal planes have resolution that approach the 2.5 mm slice 
thickness at this time.
Mean MRI volume (cm3) Mean UST volume (cm3) p Value
1224 1089 0.113
Table 2. Volume comparison.
Figure 11. The spatial resolution of each modality was estimated using profile cuts of thin features using, the full-width, 
half-maximum criterion, as illustrated.
Resolution UST MRI
Coronal 0.7 ± 0.1 mm 1.6 ± 0.3 mm
Axial/sagittal 2.5 ± 0.5 mm 0.8 ± 0.1 mm
Table 3. Spatial resolution comparison.
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6. Lesion characterization
Ultrasound breast imaging reporting and data system (US-BI-RADS) criteria are predomi-
nantly devoted to assessment of tumor shape, margins and interaction with adjacent tissue. 
However, criteria such as shadowing or enhanced through transmission are not applicable to 
UST’s circular geometry. In addition, UST, operating at 3 MHz, appears more sensitive to the 
specular reflectors of benign mass capsules, or the spiculations and/or architectural distortions 
of many cancers. Therefore, we developed a 5-point scale that combined US-BI-RADS criteria 
for tumor margins, as well as possibilities for peritumoral tissue interaction (Figure 12).
Masses were characterized by a (i) Margin Boundary score, (ii) reflectivity, (iii) quantitative SS 
evaluation and (iv) ATT evaluations. A semi-automatic region-of-interest (ROI) tool was used 
to determine the quantitative properties of each mass. After identifying the mass of interest, 
a simple elliptical ROI is drawn around the mass. The ROI algorithm then generates 20 radial 
ellipsoids – 10 inside and 10 outside the mass. Quantitative information was then measured 
for each of the 20 annuli for subsequent analysis. The region of interest (ROI) analysis was 
performed on all identified lesions using all three UST image types. Combinations of the ROI 
generated values were used to characterize all masses in the study.
Ongoing analyses of the ROI tool have not yet led to full evaluation of second and third-
order statistics of textural analyses, as well as their impacts upon decision analysis and pre-
dictive values. However, our recent RSNA presentation highlighted the significant impacts 
of first-order statistics such as standard deviation, within the tumoral ROI and comparisons 
with the surrounding peritumoral region [69]. Scatterplots and box plots of the optimal 
methods were used to illustrate the characterization potential. The box plot in Figure 13 
shows the differentiation achieved when using the boundary score (Figure 6) combined 
with the first-order statistic of standard deviation, a more crude measure of heterogeneity, 
based upon tumoral ROI extracted from ATT images, which had only slightly higher sig-
nificance than SS [69]. These ROIs were again obtained by simply drawing an elliptical ROI 
around the mass and determining the standard deviation with in the ROI. The box plot was 
based on taking the average values for 107 benign lesions and 31 cancers [69].
Upon further investigation, it was found that the SS of the peritumoral mass region (defined 
by an annular area just outside the mass boundary ROI) further separated the benign masses 
from cancer. A scatter plot based on all of these parameters is shown in Figure 14. The scat-
ter plot shows separately the cancers, fibroadenomas and cancers. The cancers are tightly 
Figure 12. Schematic of shape and margin analysis and associated grading scheme.
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Figure 13. Separation of cancer from benign when using boundary score and hetrogeneity score.
Figure 14. Scatter plot showing the distribution of cancers (squares), Fibroadenomas (diamonds), cysts (triangles) and 
other benign (circles).
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grouped in the top left corner of the plot indicating high boundary scores, high heterogene-
ity and lower peritumoral sound speed. By these measures, there was not much separation 
between cysts and fibroadenomas but significant separation between them and cancer. ROC 
analysis of the data represented in the scatter plot indicates a PPV of 91% when the sensitivity 
is 97%. However, this is a subset of data relative to an expanded ongoing study that includes 
more quantitative margin analyses. The ultimate goal is to generate textural analyses that will 
be less operator dependent and serve as appropriate diagnostic aids for a detected mass by 
simply requiring the radiologist to draw an ellipsoidal ROI. This method can also serve as a 
teaching tool for identifying grossly apparent textural differences within the tumor and sur-
rounding peritumoral region. Figure 15 shows the basic differences in sound speed texture 
noted for many cysts, fibroadenomas and cancer.
7. Conclusions
In this study we reviewed the status of breast cancer screening and the potential role that 
ultrasound tomography (UST) could play in breast imaging. Several results from recent ongo-
ing UST studies were used in this review. The main conclusions from those studies are:
(i) UST sound speed demonstrated a high degree of correlation of breast tissue structures 
relative to fat subtracted contrast-enhanced MRI. This correlation of structures was most 
evident in the coronal plane comparisons.
(ii) UST can scan ~90% of the volume of the breast compared to MRI. With proper position-
ing UST can image the pectoralis muscle and a portion of the axillary tissue.
(iii) UST demonstrated a spatial resolution of 0.7mm in the coronal plane, similar to MRI.
(iv) Initial clinical results suggest an ability to characterize lesions using margin boundary 
scores in combination with sound speed and attenuation parameters. These parameters 
leverage all three imaging modes of UST (reflection, sound speed and attenuation).
Figure 15. Cyst, fibroadenoma, cancer: Waveform SS images showing well circumscribed margins and smooth internal 
textures for both the 1.5 cm cyst in dense white breast tissue (left) and the 0.7 cm fibroadenoma (middle) in darker fat. 
The 1.8 cm cancer (right) has irregular margins, heterogeneous content and subtle peritumoral spiculations.
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UST is a promising new modality that has the potential to complement existing breast imag-
ing methods to aid in lesion detection and characterization. Future larger scale studies will 
assess UST’s role in diagnostic and screening settings.
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